RadNet, Inc. (NASDAQ:RDNT) Q3 2023 Earnings Call Transcript

But the third one that I want to mention is the fact that we have committed to a substantial investment and transition inside RadNet to artificial intelligence, both on the clinical and operational side will allow us, as RadNet performs today and into the future as well as taking on other expanded relationships. Whether they’re with our joint venture partners, new acquisitions or something transformational that will allow us to run the company in a way that doesn’t burden us like it does today with the need for more and more human capital. So our AI capital becomes really the driver in our ability to take the almost 400 centers that we’ll have by early next year and create a sizable business beyond that. And I want to leave everybody with that commitment on the part of RadNet to make the investments that will not only make RadNet a bigger and better company, but which will have ultimately enormous benefit to the most important asset we have, and that’s our customer base, our patients.

So I think we’re in a much different place today than we were even a year ago. And I think the future for RadNet and all of its employees and shareholders is very rosy.

Ed Kressler: Thank you so much for all the color.

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Dr. Berger for any closing remarks.

Howard Berger: Right. Thank you, again. And I would like to take the opportunity to thank all of our shareholders for their continued support, and particularly the employees of RadNet for their dedication and hard work. Management will continue its endeavor to be a market leader that provides great services with an appropriate return on investment for all of our stakeholders. Thank you for your time today, and I look forward to our next call. Good day.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may all now disconnect.